| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | THERAMIX LLC | 1045 CALIFORNIA ST | MOUNTAIN VIEW | CA | 94041-1926 | SANTA CLARA | USA | R43ES034324 | Toxicological screening in a single animal format | 000 | 1 | NIH | 3/6/2025 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $259,613 ) |
| | 2022 | 2022 | THERAMIX LLC | 1045 CALIFORNIA ST | MOUNTAIN VIEW | CA | 94041 | SANTA CLARA | USA | R43ES034324 | Toxicological screening in a single animal format | 000 | 1 | NIH | 9/23/2022 | $259,613 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | THERAMIX LLC | 1045 CALIFORNIA ST STE A | MOUNTAIN VIEW | CA | 94041-1926 | SANTA CLARA | USA | R43OD023258 | Creating a bioluminescent mouse model for fast screening of drugs | 000 | 1 | NIH | 7/18/2019 | $0 |
| | 2019 | 2017 | THERAMIX LLC | 1045 CALIFORNIA ST STE A | MOUNTAIN VIEW | CA | 94041-1926 | SANTA CLARA | USA | R43ES028186 | A new imaging-based rapid in vivo toxicological screening method | 000 | 1 | NIH | 6/28/2019 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $434,260 ) |
| | 2017 | 2017 | THERAMIX LLC | 1045 CALIFORNIA ST STE A | MOUNTAIN VIEW | CA | 94041-1926 | SANTA CLARA | USA | R43OD023258 | Creating a bioluminescent mouse model for fast screening of drugs | 000 | 1 | NIH | 8/11/2017 | $217,130 |
| | 2017 | 2017 | THERAMIX LLC | 1045 CALIFORNIA ST STE A | MOUNTAIN VIEW | CA | 94041-1926 | SANTA CLARA | USA | R43ES028186 | A new imaging-based rapid in vivo toxicological screening method | 000 | 1 | NIH | 7/28/2017 | $217,130 |
|
|
